Showing results (1201-1210 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|February 10, 2015
Addition of Aprepitant (Emend®) to Standard Antiemetic Regimen Continued for 7 Days after Chemotherapy for Stem Cell Transplantation Provides Significant Reduction of VomitingAnncarin Svanberg, Gunnar Birgegård
Oncology|March 21, 2015
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic MeningitisFranziska Jahn, Karin Jordan, Timo Behlendorf, et al.
Oncology|February 28, 2015
Immediate postoperative inflammation is an important prognostic factor in breast cancerSe Kyung Lee, Min-Young Choi, Soo Youn Bae, et al.
Oncology|February 28, 2015
Expression of aquaporin-1, aquaporin-3, and aquaporin-5 correlates with nodal metastasis in colon cancerByung Woog Kang, Jong Gwang Kim, Soo Jung Lee, et al.
Oncology|March 14, 2015
Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer?Jung Wook Huh, Hee Cheol Kim, Hee Chul Park, et al.
Oncology|March 21, 2015
Randomized Controlled Trial Comparing the Efficacy of Impedance Control and Temperature Control of Radiofrequency Interstitial Thermal Ablation for Treating Small Hepatocellular CarcinomaTaito Fukushima, Kenji Ikeda, Yusuke Kawamura, et al.
Oncology|April 1, 2015
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal AdenocarcinomaDmitry Bichev, Christoph Treese, Moritz von Winterfeld, et al.
Oncology|March 14, 2015
Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLCAlexios S Strimpakos, Udai Banerji, Parames Thavasu, et al.
Oncology|March 14, 2015
Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant ChemotherapyPietro Addeo, Edoardo Rosso, Pascal Fuchshuber, et al.
Oncology|January 1, 1989
Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinomaH Lupera, J P Droz, G Piot, et al.
Pageof 526